Is Advanced Medical Solutions Group plc's (LON:AMS) P/E Ratio Really That Good?

This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll show how you can use Advanced Medical Solutions Group plc's (LON:AMS) P/E ratio to inform your assessment of the investment opportunity. What is Advanced Medical Solutions Group's P/E ratio? Well, based on the last twelve months it is 29.06. That means that at current prices, buyers pay £29.06 for every £1 in trailing yearly profits.

Check out our latest analysis for Advanced Medical Solutions Group

Advertisement

How Do You Calculate A P/E Ratio?

The formula for price to earnings is:

Price to Earnings Ratio = Price per Share ÷ Earnings per Share (EPS)

Or for Advanced Medical Solutions Group:

P/E of 29.06 = GBP2.82 ÷ GBP0.10 (Based on the trailing twelve months to June 2019.)

Is A High Price-to-Earnings Ratio Good?

A higher P/E ratio means that investors are paying a higher price for each GBP1 of company earnings. All else being equal, it's better to pay a low price -- but as Warren Buffett said, 'It's far better to buy a wonderful company at a fair price than a fair company at a wonderful price'.

How Does Advanced Medical Solutions Group's P/E Ratio Compare To Its Peers?

One good way to get a quick read on what market participants expect of a company is to look at its P/E ratio. If you look at the image below, you can see Advanced Medical Solutions Group has a lower P/E than the average (33.4) in the medical equipment industry classification.

AIM:AMS Price Estimation Relative to Market, February 4th 2020
AIM:AMS Price Estimation Relative to Market, February 4th 2020

This suggests that market participants think Advanced Medical Solutions Group will underperform other companies in its industry. Many investors like to buy stocks when the market is pessimistic about their prospects. You should delve deeper. I like to check if company insiders have been buying or selling.

How Growth Rates Impact P/E Ratios

Probably the most important factor in determining what P/E a company trades on is the earnings growth. That's because companies that grow earnings per share quickly will rapidly increase the 'E' in the equation. Therefore, even if you pay a high multiple of earnings now, that multiple will become lower in the future. So while a stock may look expensive based on past earnings, it could be cheap based on future earnings.

Advanced Medical Solutions Group's earnings per share fell by 5.0% in the last twelve months. But it has grown its earnings per share by 11% per year over the last five years.

Remember: P/E Ratios Don't Consider The Balance Sheet

It's important to note that the P/E ratio considers the market capitalization, not the enterprise value. In other words, it does not consider any debt or cash that the company may have on the balance sheet. Theoretically, a business can improve its earnings (and produce a lower P/E in the future) by investing in growth. That means taking on debt (or spending its cash).

While growth expenditure doesn't always pay off, the point is that it is a good option to have; but one that the P/E ratio ignores.

Is Debt Impacting Advanced Medical Solutions Group's P/E?

With net cash of UK£64m, Advanced Medical Solutions Group has a very strong balance sheet, which may be important for its business. Having said that, at 11% of its market capitalization the cash hoard would contribute towards a higher P/E ratio.

The Verdict On Advanced Medical Solutions Group's P/E Ratio

Advanced Medical Solutions Group's P/E is 29.1 which is above average (18.0) in its market. The recent drop in earnings per share might keep value investors away, but the relatively strong balance sheet will allow the company time to invest in growth. Clearly, the high P/E indicates shareholders think it will!

Investors have an opportunity when market expectations about a stock are wrong. As value investor Benjamin Graham famously said, 'In the short run, the market is a voting machine but in the long run, it is a weighing machine. So this free visualization of the analyst consensus on future earnings could help you make the right decision about whether to buy, sell, or hold.

Of course, you might find a fantastic investment by looking at a few good candidates. So take a peek at this free list of companies with modest (or no) debt, trading on a P/E below 20.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.

About AIM:AMS

Advanced Medical Solutions Group

Develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, France, Europe, the United States, and internationally.

Excellent balance sheet with reasonable growth potential.

Similar Companies

Advertisement

Weekly Picks

LO
Lou_Basenese
VTIX logo
Lou_Basenese on Virtuix Holdings ·

From a “Shark Tank” Snub to an Air Force “Yes”: Why Virtuix at $3.50 May Be the Market’s Most Mispriced AI Story

Fair Value:US$7.562.8% undervalued
26 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
IN
Investingwilly
MA logo
Investingwilly on Mastercard ·

Mastercard: The Best Dividend Stock You're Ignoring

Fair Value:US$75033.5% undervalued
73 users have followed this narrative
1 users have commented on this narrative
9 users have liked this narrative
TR
tripledub
INTU logo
tripledub on Intuit ·

A Wonderful Business at a Not-So-Wonderful Price

Fair Value:US$56052.2% undervalued
65 users have followed this narrative
4 users have commented on this narrative
30 users have liked this narrative
TA
Talos
HYFT logo
Talos on MindWalk Holdings ·

The Asymmetric TechBio Play: MindWalk Holdings and the Valuation Disconnect

Fair Value:US$8.2780.9% undervalued
36 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative

Updated Narratives

AN
GEOHAN logo
Anthony_Lee on Geohan Corporation Berhad ·

Geohan's Growth Outlook Brightens on Expanding Order Book and Easing Cost Pressures

Fair Value:RM 0.7461.5% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
CSL logo
danmad on CSL ·

Strong buy. World-leading healthcare company with steady growth

Fair Value:AU$143.1519.4% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
RO
RockeTeller
ORE logo
RockeTeller on Orezone Gold ·

Orezone Gold Could 3X–5X, Bomboré Ramp + Casa Berardi Quebec Asset Delivers 160-180Koz in 2026

Fair Value:CA$10.6878.4% undervalued
14 users have followed this narrative
4 users have commented on this narrative
1 users have liked this narrative

Popular Narratives

IN
Investingwilly
MA logo
Investingwilly on Mastercard ·

Mastercard: The Best Dividend Stock You're Ignoring

Fair Value:US$75033.5% undervalued
73 users have followed this narrative
1 users have commented on this narrative
9 users have liked this narrative
HA
HarishPK
ADBE logo
HarishPK on Adobe ·

Adobe: A Probabilistic Case for Undervaluation

Fair Value:US$319.9636.6% undervalued
62 users have followed this narrative
9 users have commented on this narrative
19 users have liked this narrative
MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7442.1% undervalued
68 users have followed this narrative
0 users have commented on this narrative
17 users have liked this narrative